keyword
https://read.qxmd.com/read/38631714/efficacy-of-lcmv-based-cancer-immunotherapies-is-unleashed-by-intratumoral-injections-of-polyi-c
#1
JOURNAL ARTICLE
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
BACKGROUND: Lymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and humans. LCMV has been engineered for the development of cancer immunotherapies, currently undergoing evaluation in phase I/II clinical trials. Initial findings have demonstrated safety and an exceptional ability to activate and expand tumor-specific T lymphocytes. Combination strategies to maximize the antitumor effectiveness of LCMV-based immunotherapies are being explored...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38630413/inborn-errors-of-immunity-in-jordan-first-report-from-a-tertiary-referral-center
#2
JOURNAL ARTICLE
Raed Alzyoud, Motasem Alsuweiti, Heba Maaitah, Boshra Aladaileh, Mohammed Noubani, Hamazh Nsour
PURPOSE: Inborn errors of immunity (IEI) are a heterogeneous group of diseases with variable clinical phenotypes. This study was conducted to describe the epidemiology, clinical presentations, treatment, and outcome of IEI in Jordanian children. METHODS: A retrospective data analysis was conducted for children under 15 years diagnosed with IEI from the pediatric Allergy, Immunology, and Rheumatology Division-based registry at Queen Rania Children's Hospital, Amman, Jordan, between 2010 and 2022...
April 17, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38627815/inhibition-of-autophagy-related-protein-7-enhances-anti-tumor-immune-response-and-improves-efficacy-of-immune-checkpoint-blockade-in-microsatellite-instability-colorectal-cancer
#3
JOURNAL ARTICLE
Wenxin Zhang, Lu Chen, Jiafeng Liu, Bicui Chen, Huanying Shi, Haifei Chen, Huijie Qi, Zimei Wu, Xiang Mao, Xinhai Wang, Yuxin Huang, Jiyifan Li, Zheng Yu, Mingkang Zhong, Tianxiao Wang, Qunyi Li
BACKGROUND: The efficacy of anti-PD-1 therapy is primarily hindered by the limited T-cell immune response rate and immune evasion capacity of tumor cells. Autophagy-related protein 7 (ATG7) plays an important role in autophagy and it has been linked to cancer. However, the role of ATG7 in the effect of immune checkpoint blockade (ICB) treatment on high microsatellite instability (MSI-H)/mismatch repair deficiency (dMMR) CRC is still poorly understood. METHODS: In this study, patients from the cancer genome altas (TCGA) COAD/READ cohorts were used to investigate the biological mechanism driving ATG7 development...
April 16, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38612902/agnostic-administration-of-targeted-anticancer-drugs-looking-for-a-balance-between-hype-and-caution
#4
REVIEW
Svetlana N Aleksakhina, Alexander O Ivantsov, Evgeny N Imyanitov
Many tumors have well-defined vulnerabilities, thus potentially allowing highly specific and effective treatment. There is a spectrum of actionable genetic alterations which are shared across various tumor types and, therefore, can be targeted by a given drug irrespective of tumor histology. Several agnostic drug-target matches have already been approved for clinical use, e.g., immune therapy for tumors with microsatellite instability (MSI) and/or high tumor mutation burden (TMB), NTRK1-3 and RET inhibitors for cancers carrying rearrangements in these kinases, and dabrafenib plus trametinib for BRAF V600E mutated malignancies...
April 7, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38587186/arid1a-regulates-dna-repair-through-chromatin-organization-and-its-deficiency-triggers-dna-damage-mediated-anti-tumor-immune-response
#5
JOURNAL ARTICLE
Ali Bakr, Giuditta Della Corte, Olivera Veselinov, Simge Kelekçi, Mei-Ju May Chen, Yu-Yu Lin, Gianluca Sigismondo, Marika Iacovone, Alice Cross, Rabail Syed, Yunhee Jeong, Etienne Sollier, Chun-Shan Liu, Pavlo Lutsik, Jeroen Krijgsveld, Dieter Weichenhan, Christoph Plass, Odilia Popanda, Peter Schmezer
AT-rich interaction domain protein 1A (ARID1A), a SWI/SNF chromatin remodeling complex subunit, is frequently mutated across various cancer entities. Loss of ARID1A leads to DNA repair defects. Here, we show that ARID1A plays epigenetic roles to promote both DNA double-strand breaks (DSBs) repair pathways, non-homologous end-joining (NHEJ) and homologous recombination (HR). ARID1A is accumulated at DSBs after DNA damage and regulates chromatin loops formation by recruiting RAD21 and CTCF to DSBs. Simultaneously, ARID1A facilitates transcription silencing at DSBs in transcriptionally active chromatin by recruiting HDAC1 and RSF1 to control the distribution of activating histone marks, chromatin accessibility, and eviction of RNAPII...
April 8, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38586647/spontaneous-regression-of-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-in-an-hiv-positive-patient-a-case-report-and-literature-review
#6
Evelyn Li Yuen Khaw, Wee Fu Gan, Nor Zaila Zaidan
Individuals infected with human immunodeficiency virus (HIV) have a greater risk of developing malignancies, including both acquired immunodeficiency syndrome (AIDS)-defining malignancies as well as many non-AIDS-defining cancers. Several factors contribute to the increased incidence of malignancies in this population such as the direct effects of HIV itself, immune deficiency, co-infection with oncogenic viruses, environmental factors, and the effects of combination antiretroviral therapy (cART). The improvement of the immune response following the introduction of cART results in a better response to conventional therapies for malignancies, including chemotherapy, radiotherapy, and surgery...
March 2024: Curēus
https://read.qxmd.com/read/38574321/platelet-derived-tgf-%C3%AE-1-induces-functional-reprogramming-of-myeloid-derived-suppressor-cells-in-immune-thrombocytopenia
#7
JOURNAL ARTICLE
Lingjun Wang, Haoyi Wang, Mingfang Zhu, Xiaofei Ni, Lu Sun, Wanru Wang, Jie Xie, Yubin Li, Yitong Xu, Ruting Wang, Shouqing Han, Ping Zhang, Jun Peng, Ming Hou, Yu Hou
Platelet α-granules are rich in TGF-β1 which is associated with myeloid-derived suppressor cell (MDSC) biology. Responders to thrombopoietin receptor agonists (TPO-RAs) revealed a parallel increase in the number of both platelets and MDSCs. Here, anti-CD61 immune-sensitized splenocytes were transferred into severe combined immunodeficient mice to establish an active murine model of immune thrombocytopenia (ITP). Subsequently, we demonstrated that TPO-RAs augmented the inhibitory activities of MDSCs by arresting plasma cells differentiation, reducing Fas ligand expression on cytotoxic T cells, and re-balancing T cell subsets...
April 4, 2024: Blood
https://read.qxmd.com/read/38570506/loss-of-crebbp-and-kmt2d-cooperate-to-accelerate-lymphomagenesis-and-shape-the-lymphoma-immune-microenvironment
#8
JOURNAL ARTICLE
Jie Li, Christopher R Chin, Hsia-Yuan Ying, Cem Meydan, Matthew R Teater, Min Xia, Pedro Farinha, Katsuyoshi Takata, Chi-Shuen Chu, Yiyue Jiang, Jenna Eagles, Verena Passerini, Zhanyun Tang, Martin A Rivas, Oliver Weigert, Trevor J Pugh, Amy Chadburn, Christian Steidl, David W Scott, Robert G Roeder, Christopher E Mason, Roberta Zappasodi, Wendy Béguelin, Ari M Melnick
Despite regulating overlapping gene enhancers and pathways, CREBBP and KMT2D mutations recurrently co-occur in germinal center (GC) B cell-derived lymphomas, suggesting potential oncogenic cooperation. Herein, we report that combined haploinsufficiency of Crebbp and Kmt2d induces a more severe mouse lymphoma phenotype (vs either allele alone) and unexpectedly confers an immune evasive microenvironment manifesting as CD8+ T-cell exhaustion and reduced infiltration. This is linked to profound repression of immune synapse genes that mediate crosstalk with T-cells, resulting in aberrant GC B cell fate decisions...
April 3, 2024: Nature Communications
https://read.qxmd.com/read/38534141/the-association-of-intraocular-efavirenz-concentrations-and-hiv-1-viral-load-among-persons-with-hiv
#9
JOURNAL ARTICLE
Yiwen Qian, Pei Zhang, Luoziyi Wang, Jinshan Suo, Lin Yin, Yuceng Wang, Lijun Zhang, Zhiliang Wang
OBJECTIVE: Efavirenz (EFV) is commonly used in combination antiretroviral therapy (cART). However, in our previous study, many persons living with human immunodeficiency virus (HIV) exhibited ocular complications despite undergoing effective cART. Here, we aimed to determine the intraocular EFV concentrations in the vitreous and analyze the factors affecting viral load in the vitreous in patients with HIV-associated retinopathies. DESIGN: Observational, retrospective study...
March 25, 2024: Journal of Acquired Immune Deficiency Syndromes: JAIDS
https://read.qxmd.com/read/38503300/expanding-the-praas-spectrum-de-novo-mutations-of-immunoproteasome-subunit-%C3%AE-type-10-in-six-infants-with-scid-omenn-syndrome
#10
JOURNAL ARTICLE
Caspar I van der Made, Simone Kersten, Odelia Chorin, Karin R Engelhardt, Gayatri Ramakrishnan, Helen Griffin, Ina Schim van der Loeff, Hanka Venselaar, Annick Raas Rothschild, Meirav Segev, Janneke H M Schuurs-Hoeijmakers, Tuomo Mantere, Rick Essers, Masoud Zamani Esteki, Amir L Avital, Peh Sun Loo, Annet Simons, Rolph Pfundt, Adilia Warris, Marieke M Seyger, Frank L van de Veerdonk, Mihai G Netea, Mary A Slatter, Terry Flood, Andrew R Gennery, Amos J Simon, Atar Lev, Shirley Frizinsky, Ortal Barel, Mirjam van der Burg, Raz Somech, Sophie Hambleton, Stefanie S V Henriet, Alexander Hoischen
Mutations in proteasome β-subunits or their chaperone and regulatory proteins are associated with proteasome-associated autoinflammatory disorders (PRAAS). We studied six unrelated infants with three de novo heterozygous missense variants in PSMB10, encoding the proteasome β2i-subunit. Individuals presented with T-B-NK± severe combined immunodeficiency (SCID) and clinical features suggestive of Omenn syndrome, including diarrhea, alopecia, and desquamating erythematous rash. Remaining T cells had limited T cell receptor repertoires, a skewed memory phenotype, and an elevated CD4/CD8 ratio...
March 12, 2024: American Journal of Human Genetics
https://read.qxmd.com/read/38500582/normal-distribution-of-h3k9me3-occupancy-co-mediated-by-histone-methyltransferase-bcdim5-and-histone-deacetylase-bchda1-maintains-stable-aba-synthesis-in-botrytis-cinerea-tb-31
#11
JOURNAL ARTICLE
Zhao Wei, Dan Shu, Xiaonan Hou, Tianfu Li, Zhemin Li, Di Luo, Jie Yang, Hong Tan
Abscisic acid (ABA) is a conserved and important "sesquiterpene signaling molecule" widely distributed in different organisms with unique biological functions. ABA coordinates reciprocity and competition between microorganisms and their hosts. In addition, ABA also regulates immune and stress responses in plants and animals. Therefore, ABA has a wide range of applications in agriculture, medicine and related fields. The plant pathogenic ascomycete B. cinerea has been extensively studied as a model strain for ABA production...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38486019/anaphylactic-degranulation-by-mast-cells-requires-the-mobilization-of-inflammasome-components
#12
JOURNAL ARTICLE
Andrea Mencarelli, Pradeep Bist, Hae Woong Choi, Hanif Javanmard Khameneh, Alessandra Mortellaro, Soman N Abraham
The inflammasome components NLRP3 and ASC are cytosolic proteins, which upon sensing endotoxins or danger cues, form multimeric complexes to process interleukin (IL)-1β for secretion. Here we found that antigen (Ag)-triggered degranulation of IgE-sensitized mast cells (MCs) was mediated by NLRP3 and ASC. IgE-Ag stimulated NEK7 and Pyk2 kinases in MCs to induce the deposition of NLRP3 and ASC on granules and form a distinct protein complex (granulosome) that chaperoned the granules to the cell surface...
March 14, 2024: Nature Immunology
https://read.qxmd.com/read/38485907/description-of-a-novel-pathogenic-variant-in-the-arpc1b-and-a-severe-allergy-in-two-infants
#13
JOURNAL ARTICLE
Oscar Zaveleta Martínez, Ana Eunice Fregoso-Zuñiga, Cielo Razo Requena, Sara Espinosa Padilla, Lzbeth Blancas Galicia
Actinrelated protein 2/3 complex subunit 1B (ARPC1B) deficiency is an inborn error of immunity (IEI) characterized by a combination of immunodeficiency and immune dysregulation and classified as an IEI with allergic manifestations. Here, we describe two patients with pathogenic variants in the ARPC1B gene. The first patient presented with eczema and bronchospasm at six months of age. The second patient presented with eczema and milk protein allergy at five months of age. The c.899_944 (p.Glu300Glyfs*7) pathogenic variant was previously described, whereas the c...
February 11, 2024: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/38461691/transforming-the-landscape-of-colorectal-cancer-treatment-with-immunotherapy-evolution-and-future-horizons
#14
JOURNAL ARTICLE
Jan Clerick, Aude Van Oosterwyck, Saskia Carton
Colorectal cancer (CRC) continues to be one of the most prevalent and lethal cancers worldwide. Over the past decades, immune checkpoint inhibitors (ICIs) have shown to significantly improve patient outcomes in mismatch repair-deficient metastasized CRC. However, widening the scope of this novel treatment modality has been the object of growing interest. This article will review several landmark trials, while exploring various aspects of this rapidly evolving field, including potential neoadjuvant (or even entirely nonsurgical) and adjuvant indications in localized disease...
March 5, 2024: Cancer Treatment and Research Communications
https://read.qxmd.com/read/38460933/transcriptomic-and-proteomic-study-of-cancer-cell-lines-exposed-to-actinomycin-d-and-nutlin-3a-reveals-numerous-novel-candidates-for-p53-regulated-genes
#15
JOURNAL ARTICLE
Barbara Łasut-Szyszka, Agnieszka Gdowicz-Kłosok, Beata Małachowska, Małgorzata Krześniak, Agnieszka Będzińska, Marta Gawin, Monika Pietrowska, Marek Rusin
Transcriptomic analyses have revealed hundreds of p53-regulated genes; however, these studies used a limited number of cell lines and p53-activating agents. Therefore, we searched for candidate p53-target genes by employing stress factors and cell lines never before used in a high-throughput search for p53-regulated genes. We performed RNA-Seq on A549 cells exposed to camptothecin, actinomycin D, nutlin-3a, as well as a combination of actinomycin D and nutlin-3a (A + N). The latter two substances synergise upon the activation of selected p53-target genes...
March 7, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38441998/antagonistic-effects-of-the-cytotoxic-molecules-granzyme-b-and-trail-in-the-immunopathogenesis-of-sclerosing-cholangitis
#16
JOURNAL ARTICLE
Mareike Kellerer, Sana Javed, Christian Casar, Nico Will, Laura K Berkhout, Dorothee Schwinge, Christian F Krebs, Christoph Schramm, Katrin Neumann, Gisa Tiegs
BACKGROUND AIMS: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary inflammation and fibrosis. We showed an elevated interferon (IFN)γ response in PSC patients and in multidrug resistance protein 2-deficient (Mdr2-/-) mice developing sclerosing cholangitis. Interferon (IFN)γ induced expression of the cytotoxic molecules granzyme B (GzmB) and TNF-related apoptosis-inducing ligand (TRAIL) in hepatic lymphocytes and mediated liver fibrosis in sclerosing cholangitis...
March 5, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38441205/a-large-single-center-cohort-of-bare-lymphocyte-syndrome-immunological-and-genetic-features-in-turkey
#17
JOURNAL ARTICLE
Hilal Ünsal, Canan Caka, Hacer Neslihan Bildik, Saliha Esenboğa, Alphan Kupesiz, Barış Kuşkonmaz, Duygu Uçkan Cetinkaya, Mirjam van der Burg, İlhan Tezcan, Deniz Çağdaş
Major histocompatibility complex class II (MHC-II) deficiency or bare lymphocyte syndrome (BLS) is a rare, early-onset, autosomal recessive, and life-threatening inborn error of immunity. We aimed to assess the demographic, clinical, laboratory, follow-up, and treatment characteristics of patients with MHC-II deficiency, together with their survival. We retrospectively investigated 21 patients with MHC-II deficiency. Female/male ratio was 1.63. The median age at diagnosis was 16.3 months (5 months-9...
January 2024: Scandinavian Journal of Immunology
https://read.qxmd.com/read/38437854/crohn-s-disease
#18
REVIEW
Michael Dolinger, Joana Torres, Severine Vermeire
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract that might lead to progressive bowel damage and disability. The exact cause of Crohn's disease is unknown, but evidence points towards multifactorial events causing dysregulation of the innate immune system in genetically susceptible people. Commonly affecting the terminal ileum and proximal colon, Crohn's disease inflammation is often discontinuous and patchy, segmental, and transmural. Identification of characteristic findings on ileocolonoscopy and histology remains the diagnostic gold standard, but complete assessment involves laboratory abnormalities, including micronutrient deficiencies, cross-sectional imaging to identify transmural disease extent, severity and complications, and a psychosocial assessment...
March 1, 2024: Lancet
https://read.qxmd.com/read/38424321/novel-presentation-of-major-histocompatibility-complex-class-ii-deficiency-with-hemophagocytic-lymphohistiocytosis
#19
JOURNAL ARTICLE
Fayhan J Alroqi, Musaab A Alhezam, Abdullah I Almojali, Tlili Barhoumi, Nouf Althubaiti, Yousef Alharbi, Mohammed A Al Balwi, Abdulrahman Alrasheed
PURPOSE: Major histocompatibility complex (MHC) class II deficiency is one of the combined immune deficiency disorders caused by defects in the MHC class II regulatory genes leading to abnormal T cells development and function. Therefore, patients mainly present with increased susceptibility to infections, diarrhea, and failure to thrive. In this report, we present one MHC class II deficient patient with a novel presentation with Hemophagocytic Lymphohistiocytosis (HLH). METHODS: Immunophenotyping of lymphocyte subpopulations and HLA-DR expression was assess by flow cytometry...
March 1, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38415256/hlh-as-an-additional-warning-sign-of-inborn-errors-of-immunity-beyond-familial-hlh-in-children-a-systematic-review
#20
Silvia Ricci, Walter Maria Sarli, Lorenzo Lodi, Clementina Canessa, Francesca Lippi, Donata Dini, Marta Ferrari, Laura Pisano, Elena Sieni, Giuseppe Indolfi, Massimo Resti, Chiara Azzari
BACKGROUND: Hemophagocytic Lymphohistiocytosis (HLH) is a rare and life-threatening condition characterized by a severe impairment of the immune homeostasis. While Familial-HLH (FHL) is a known cause, the involvement of other Inborn Errors of Immunity (IEI) in pediatric-HLH remains understudied. OBJECTIVE: This systematic review aimed to assess the clinical features, triggers, laboratory data, treatment, and outcomes of pediatric HLH patients with IEI other than FHL (IEInotFHL), emphasizing the importance of accurate identification and management...
2024: Frontiers in Immunology
keyword
keyword
68869
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.